KINTO Trademark

Trademark Overview

On Friday, November 8, 2019, a trademark application was filed for KINTO with the United States Patent and Trademark Office. The USPTO has given the KINTO trademark a serial number of 88685412. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 12, 2023. This trademark is owned by VistaPharm, Inc.. The KINTO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating thyroid conditions, autoimmune diseases and cancer
kinto

General Information

Serial Number88685412
Word MarkKINTO
Filing DateFriday, November 8, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 12, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 14, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for treating thyroid conditions, autoimmune diseases and cancer
Translation of Words in MarkThe wording "KINTO" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 15, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVistaPharm, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Providence, NJ 07974
Party NameVistaPharm, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Providence, NJ 07974

Trademark Events

Event DateEvent Description
Monday, June 12, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 12, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, November 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 7, 2022SOU EXTENSION 2 GRANTED
Monday, November 7, 2022SOU EXTENSION 2 FILED
Monday, November 7, 2022TEAS EXTENSION RECEIVED
Wednesday, August 3, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, May 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 9, 2022SOU EXTENSION 1 GRANTED
Monday, May 9, 2022SOU EXTENSION 1 FILED
Monday, May 9, 2022TEAS EXTENSION RECEIVED
Tuesday, November 9, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 14, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 14, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 14, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 14, 2021PUBLISHED FOR OPPOSITION
Thursday, August 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 8, 2021SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Friday, August 14, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, August 14, 2020LETTER OF SUSPENSION E-MAILED
Friday, August 14, 2020SUSPENSION LETTER WRITTEN
Thursday, August 13, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 13, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 13, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 13, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 13, 2020NON-FINAL ACTION E-MAILED
Thursday, February 13, 2020NON-FINAL ACTION WRITTEN
Wednesday, February 12, 2020ASSIGNED TO EXAMINER
Friday, November 15, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 12, 2019NEW APPLICATION ENTERED

Related Keywords

kinto autoimmune diseases cancer conditions thyroid preparations treating pharmaceutical